CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS

Biological preparations (BP) obtained by gene engineering possess a special characteristic called immunogenicity, i.e. propensity of biological drugs to induce an undesired immune response associated with arising anti-drug antibodies. These antibodies can change BP pharmacokinetics and pharmacodynam...

Full description

Bibliographic Details
Main Authors: V. D. Nazarov, S. V. Lapin, V. A. Dobronravov, K. A. Smirnov, D. A. Mayer, T. O. Muzhetskaya, A. A. Totolian
Format: Article
Language:Russian
Published: SPb RAACI 2018-01-01
Series:Medicinskaâ Immunologiâ
Subjects:
erythropoietin
anemia
immunogenicity
antibodies
Online Access:https://www.mimmun.ru/mimmun/article/view/1440

Internet

https://www.mimmun.ru/mimmun/article/view/1440

Similar Items